| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 13.60▼ | 13.55▼ | 13.61▼ | 14.24▼ | 15.50▼ |
| MA10 | 13.58▼ | 13.66▼ | 13.56▼ | 15.37▼ | 15.10▼ |
| MA20 | 13.60▼ | 13.61▼ | 13.99▼ | 16.47▼ | 16.26▼ |
| MA50 | 13.69▼ | 14.24▼ | 14.99▼ | 15.73▼ | 11.59▲ |
| MA100 | 13.62▼ | 15.17▼ | 16.24▼ | 16.65▼ | 10.68▲ |
| MA200 | 14.14▼ | 16.37▼ | 15.94▼ | 12.90▲ | 262.92▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | 0.036▲ | 0.034▲ | -0.459▼ | -0.583▼ |
| RSI | 41.899▼ | 37.789▼ | 33.855▼ | 33.477▼ | 45.642▼ |
| STOCH | 55.061 | 38.128 | 52.770 | 5.953▼ | 37.824 |
| WILL %R | -92.308▼ | -59.809 | -71.233 | -93.012▼ | -93.506▼ |
| CCI | -100.182▼ | -21.390 | -50.447 | -138.996▼ | -130.752▼ |
|
Monday, March 23, 2026 05:56 AM
Topline data expected from Phase 2 LOTUS trial of abdakibart (AVTX-009) for the treatment of hidradenitis suppurativa in the second quarter of 2026Cash, cash equivalents and short-term investments of ...
|
|
Thursday, March 12, 2026 06:53 AM
CEO Garry Neil said the company expects to report top-line data in the second quarter from its completed Phase 2b LOTUS trial of AVTX-009 in hidradenitis suppurativa (HS), outlining what he described ...
|
|
Thursday, March 05, 2026 05:15 AM
Avalo Therapeutics (NASDAQ:AVTX) used a presentation at its 46th Annual Healthcare Conference appearance to outline its strategy for AVTX-009, a high-affinity human monoclonal antibody designed to ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/03/26 | 13.50 | 14.115 | 13.07 | 13.49 | 2,534,422 |
| 20/03/26 | 13.94 | 14.80 | 13.185 | 13.42 | 477,507 |
| 19/03/26 | 14.30 | 15.25 | 14.085 | 14.22 | 868,444 |
| 18/03/26 | 15.25 | 15.33 | 14.61 | 14.68 | 409,566 |
| 17/03/26 | 15.91 | 16.135 | 15.37 | 15.38 | 741,467 |
| 16/03/26 | 15.98 | 16.375 | 15.585 | 16.02 | 415,360 |
| 13/03/26 | 16.71 | 17.145 | 15.45 | 15.80 | 314,461 |
| 12/03/26 | 16.81 | 17.09 | 16.13 | 16.71 | 722,110 |
| 11/03/26 | 16.94 | 17.48 | 16.86 | 17.10 | 1,311,422 |
| 10/03/26 | 17.35 | 18.015 | 16.68 | 16.925 | 639,659 |
|
|
||||
|
|
||||
|
|